Keenan, LLC has filed a Form 13F-HR with the Securities and Exchange Commission, disclosing its equity holdings as of September 30, 2026. The filing lists the firm's address as 7 Bulfinch Place, Suite 302, Boston, Massachusetts, and identifies Brian Edward Keenan as the Chief Compliance Officer responsible for the report.
The portfolio consists of 47 individual positions. The largest holding disclosed is Capital Group Dividend Value Shs Crea Unit, which comprises 294,715 shares. Other significant individual stock positions include Chewy Inc. Class A with 13,299 shares, Fidelity Covington Trust Fund SMA Mid ETF with 321,869 shares, and Fidelity Covington Trust Blue Chip Growth with 431,821 shares.
The filing also includes a substantial number of exchange-traded funds (ETFs). Major holdings in this category include iShares Core S&P 500 ETF with 28,642 shares, iShares Core S&P US Value with 141,152 shares, and Schwab Strategic Trust US Large Cap Growth ETF with 14,926 shares.
The remaining positions in the filing include a mix of technology, healthcare, and energy companies. These include Advanced Micro Devices Inc., Alphabet Inc., Amazon.com Inc., Apple Inc., AstraZeneca PLC, CrowdStrike Holdings Inc., Insmed Inc., Johnson & Johnson, Mercury Systems Inc., Meta Platforms Inc., Micron Technology Inc., Microsoft Corp., NVIDIA Corp., and Takeda Pharmaceutical Co. Ltd. Sponsored ADS.
